Medical University of South Carolina

Open enrollment with an early-phase pipeline tilt

According to ClinicalTrials.gov-derived indexes, Medical University of South Carolina sits in the top decile of US sponsors by registered trial count (#44 of 15,742 sponsors by registered trial count).

755 total trials 142 currently recruiting 520 completed early-phase tilt top decile by trial count

Medical University of South Carolina: 755 sponsored US clinical trials, 142 recruiting.

Medical University of South Carolina sponsors 755 registered US clinical trials on ClinicalTrials.gov, 142 of them currently recruiting, and 520 completed. 66 of these trials are in Phase 3-4 (later-stage) and 228 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Stroke, with 15 trials.

Top-decile sponsor footprint

Medical University of South Carolina ranks in the top decile of sponsors by registered trial count (#44 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.

Trial completion reliability score

D 64/100

520 of 580 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (89.7%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.

Open and recent trials

755 total, page 14 of 16

COMPLETED Phase 2

D-Cycloserine Facilitation of Cocaine - Cue Extinction

NCT00759473

COMPLETED NA

Transcranial Magnetic Stimulation Used to Both Measure Cortical Excitability and Explore Methamphetamine Cue Craving

NCT01685463

COMPLETED Phase 1

Safety of N-acetylcysteine in Maternal Chorioamnionitis (NAC in Chorio)

NCT00724594

COMPLETED NA

Evaluating Predictors & Interventions in Sphincter of Oddi Dysfunction

NCT00688662

COMPLETED Phase 2

Stress and Medication Effects on Cocaine Cue Reactivity

NCT00613015

COMPLETED

Diabetic Retinopathy and Sickle Trait

NCT00720317

COMPLETED Phase 2

An Exploratory Study of Naltrexone Plus Aripiprazole for Alcohol Dependence

NCT00667875

TERMINATED

Endothelial Progenitor Cells in Umbilical Cord Blood in Preeclampsia and IUGR

NCT00634855

COMPLETED

Cue Induced Imaging in Nicotine Dependent Smokers

NCT00844701

COMPLETED Early Phase 1

Taliderm Dressing for Venous Ulcers

NCT00720239

COMPLETED NA

Study of the Effect of the Drug Gabapentin on Postoperative Pain and Incidence of Postoperative Nausea and Vomiting

NCT00886236

COMPLETED NA

Stress and Marijuana Cue-elicited Craving and Reactivity

NCT00613405

COMPLETED Phase 1

An Open-Label Trial of N-Acetylcysteine in Cannabis Dependent Adolescents

NCT00542750

COMPLETED

Evaluation of the Aspheric ReSTOR Intraocular Lens (IOL) After Routine Cataract Extraction

NCT00565695

COMPLETED Phase 2

Vitamin D3 Supplementation in Participants Diagnosed With Early-Stage Prostate Cancer Who Decide to Undergo Active Surveillance Treatment Regimen.

NCT01045109

COMPLETED NA

Evaluation of Blink Tears and Systane Concomitant With Restasis for the Treatment of Dry Eye Symptoms

NCT00565669

COMPLETED NA

Acrysof Toric SN60T3corneal Astigmatism Between 0.75 and 1.00 D.

NCT00542581

COMPLETED NA

Comparison of Extensible and Inextensible Lumbosacral Orthoses for Lower Back Pain

NCT01933399

COMPLETED

Evaluation of the Aspheric ReSTOR IOL After Routine Cataract Extraction

NCT00720005

COMPLETED NA

Feasibility Study of Cryotherapy for Chronic Venous Disorders

NCT00617825

COMPLETED Phase 2

The Effect of Yohimbine on Cocaine Cue Reactivity

NCT00535002

COMPLETED Phase 2

Enhancing Juvenile Drug Court Outcomes With Evidence-Based Practices

NCT01266109

COMPLETED

Alterations in the Plasma Proteome of Early-Onset Severe Preeclampsia

NCT00719654

COMPLETED

The Use of High Resolution Chest Computed Tomography in Alpha-1 Antitrypsin Deficiency

NCT00532805

COMPLETED Phase 2

Menstrual Cycle Effects on Smoking Cessation and Cue Reactivity

NCT00664755

COMPLETED NA

A Pilot Study of TMS Effects on Pain and Depression in Patients With Fibromyalgia

NCT00523302

COMPLETED NA

IV Insulin Protocol in Diabetes and Renal Transplantation

NCT00609986

COMPLETED NA

Study to Evaluate if the Drug Vasopressin Protects the Kidneys for Patients Undergoing Liver Transplant

NCT00886262

COMPLETED NA

Simulated Dawn Med Students

NCT02088593

COMPLETED Phase 4

Acamprosate vs. Placebo in Bipolar Alcoholics

NCT00466661

COMPLETED NA

Evaluating the Methylphenidate Patch to Treat Former Stimulant Users With ADHD

NCT00780208

COMPLETED NA

Preoperative Corticosteroid Therapy in Neonates Undergoing Cardiopulmonary Bypass

NCT00934843

COMPLETED Phase 2

Focal Electroconvulsive Therapy for Depression

NCT01589315

COMPLETED Phase 3

Vitamin D Status of Pregnant Women and Their Children in Eau Claire, South Carolina

NCT00412087

COMPLETED

Correlation of Intrathoracic Impedance Measures With Blood Plasma Volume in Congestive Heart Failure

NCT00603213

COMPLETED Phase 1

Vitamin D Therapy in Patients With Systemic Lupus Erythematosus (SLE)

NCT00418587

COMPLETED Phase 2

N-Acetylcysteine and Smoking Reduction

NCT00751257

COMPLETED

Screening of Bone Mineral Density in Women Who Have Received Chemotherapy

NCT00603551

TERMINATED

Predictors of Maternal Weight Gain and Neonatal Body Composition

NCT00634764

COMPLETED Phase 2

D-Cycloserine and Cue Exposure in Cocaine-Dependent Individuals

NCT00780442

COMPLETED Phase 3

Establishing the Vitamin D Requirements During Lactation

NCT00412074

COMPLETED NA

Risk Reduction for Drug Use and Sexual Revictimization

NCT00998153

COMPLETED Phase 3

Duloxetine in Patients With Suspected Functional Pancreatic/Biliary Pain (Sphincter of Oddi Dysfunction)

NCT00471315

COMPLETED

Evaluation of VisionQuest 20/20, a Visual Acuity Testing Software

NCT00366756

COMPLETED

An Assessment of Milk Thistle Pharmacokinetics and Drug Interactions

NCT00200798

COMPLETED Phase 4

Effectiveness of Naltrexone Versus Placebo to Reduce Craving for Alcohol With Evaluation of Genetic Variability.

NCT00366626

COMPLETED Phase 1

Open Label Trial of Acamprosate in Bipolar Alcoholics

NCT00330486

COMPLETED Phase 4

Acamprosate in Alcoholics With Comorbid Anxiety or Depression

NCT00330174

COMPLETED Phase 4

Comparison of Visual Outcomes and Patient Satisfaction After Cataract Surgery and Implantation of ReSTOR and ReZoom IOLs

NCT00366587

COMPLETED

Comparison of the Torsional Handpiece to Conventional Handpiece During Routine Phacoemulsification

NCT00366405

← Previous Page 14 of 16 Next →

Phase Distribution

PhaseTrial count
Phase 1 104
Phase 2 124
Phase 3 23
Phase 4 43

What is open in the Medical University of South Carolina pipeline

142 recruiting of 755 indexed (19% open); 520 completed (69%).

Phase mix: 66 late (III/IV) vs 228 early (I/II) (early-phase heavy).

Top condition: Stroke (15 trials), 9 others listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

Medical University of South Carolina: open-pipeline peers nationwide

Peers matched on 755 registered trials and 19% open enrollment, not the therapeutic-area sidebar.

Medical University of South Carolina sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 02004006008001,000 14%16%18%20%22% Total trials Recruiting share Medical University of South CarolinaUniversity of California, San DiegoThe University of Texas Health Science Center, HoustonDana-Farber Cancer InstituteUniversity of MiamiSpaulding Rehabilitation HospitalIpsenEyePoint PharmaceuticalsHebrew SeniorLife
Medical University of South Carolina sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

Medical University of South Carolina sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 755 trials (± recruiting share)

Sponsors near 19% open enrollment (± trial volume)

What to do with this Medical University of South Carolina page

755 registered trials is a research-attention snapshot, not an endorsement of Medical University of South Carolina or any single study.

  • 142 of Medical University of South Carolina's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
  • Stroke is the condition Medical University of South Carolina studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Stroke trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. Medical University of South Carolina pipeline card: 755 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.